Loading clinical trials...

RECRUITING

Early Detection of Vaping-related Vascular Diseases

NCT05454267•University of Miami

Summary

The purpose of this study is to determine how vaping affects blood vessels, in particular if early damage occurs in the lung vessels.

Eligibility

Age

18 - 40 years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•Vapers Group:
•1. Current electronic cigarette (EC) Puff Bar users defined as using EC either daily or occasionally in the past 30 days for at least 6 months, and with 5% nicotine concentration pods.
•2. Adults aged 18-40 years
•Healthy Group:
•1. Healthy never smokers, never vapers
•2. Adults aged 18-40 years

Exclusion Criteria

•1. Current or past smoking of tobacco cigarette (TC) or other tobacco/nicotine products (e.g., smokeless tobacco, Hookah) or marijuana will be excluded from the study.
•2. Subjects with self-reported history of chronic health problems including asthma, chronic obstructive pulmonary disease (COPD), morbid obesity (BMI\>40 kg/m2), hypertension or diabetes
•3. Pregnant or breastfeeding women

Locations (1)

University of Miami Health System

Miami, Florida, United States

Key Dates

Start Date

September 12, 2022

Primary Completion Date

June 30, 2026

Completion Date

December 31, 2026

Last Updated

May 28, 2025

Enrollment

ESTIMATED participants

Conditions

VapingBlood Vessel Injury

Contacts

Adam Wanner, MD

CONTACT

(305)243-2568 awanner@med.miami.edu

Michael Campos, MD

CONTACT

3052436388 mcampos1@med.miami.edu

Vape Use Among Younger & Older Smokers

NCT07214168

Smoking CigaretteSmoking Behaviors+2 more

View study

RECRUITINGNA

Cannabis THC Potency, Metabolism, and Cognitive Impairment in Young Adults

NCT06077292

Cannabis UseTHC+3 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: May 28, 2025Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Early Detection of Vaping-related Vascular Diseases

Inclusion Criteria

Exclusion Criteria

Vape Use Among Younger & Older Smokers

Cannabis THC Potency, Metabolism, and Cognitive Impairment in Young Adults

Behavioral Intervention for Youth to Promote Vaping Cessation

Nicotine Patch Plus Nicotine Mouth Spray Versus Nicotine Reduction for Vaping Cessation

Testing a School-Based E-cigarette, Tobacco, and Betel (Areca) Nut Use Prevention Curriculum for Guam Youths

High Impact E-cigarette Advertisement Features